You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 120 No. 7, July 1984 TABLE OF CONTENTS
  Archives
  •  Online Features
  CASE REPORTS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (23)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Late-Onset, Warfarin-Caused Necrosis Occurring in a Patient With Infectious Mononucleosis

Timothy R. Franson, MD; Harold D. Rose, MD; Michael R. Spivey, MD; Judith Maroney, MD; Joseph A. Libnoch, MD

Arch Dermatol. 1984;120(7):927-931.


Abstract

{dagger} A 25-year-old man with Klinefelter's syndrome and recurrent thrombophlebitis, for which he had been receiving long-term warfarin sodium therapy, had bilateral ecchymoses on the hips coincident with serologically confirmed Epstein-Barr virus-caused mononucleosis. Biopsy specimens taken from the hip lesions showed microscopic findings consistent with a diagnosis of warfarin necrosis. Direct immunofluorescence microscopy disclosed vessel-wall deposition of IgM and heavy upperdermal deposition of IgG. Electron microscopy disclosed nonspecific endothelial cell blebs that projected into the vessel lumen. The temporal association of mononucleosis with the onset of warfarin necrosis suggests that the viral illness may have precipitated an immunologic endothelial surface reaction, leading to thrombosis and secondary hemorrhage with infarction. To our knowledge, the appearance of warfarin necrosis in a patient receiving long-term, stable anticoagulation therapy has not been previously reported.

(Arch Dermatol 1984;120:927-931)



Author Affiliations

From the Sections of Infectious Disease (Drs Franson and Rose) and Hematology/Medical Oncology (Drs Spivey, Maroney, and Libnoch), Wood (Wis) Veterans Administration Medical Center; and the Department of Medicine (Drs Franson, Rose, Spivey, Maroney, and Libnoch), the Medical College of Wisconsin, Milwaukee.


Footnotes

Accepted for publication May 28, 1983.

Reprint requests to Medical Service 111, VA Medical Center, Wood, WI 53193 (Dr Rose).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Case 31-2001- A 70-Year-Old Woman with End-Stage Renal Disease and Cutaneous Ulcers
Baran and Letts
NEJM 2001;345:1119-1124.
FULL TEXT  

Warfarin Necrosis
McKnight et al.
Arch Fam Med 1992;1:105-108.
ABSTRACT  

Erythematous, Hemorrhagic, and Necrotic Plaques in an Elderly Man
Sharafuddin et al.
Arch Dermatol 1992;128:105-106.
ABSTRACT  

Coumarin Necrosis, Neonatal Purpura Fulminans, and Protein C Deficiency
Gladson et al.
Arch Dermatol 1987;123:1701a-1706a.
ABSTRACT  

Recurrent Coumarin-Induced Skin Necrosis in a Patient With an Acquired Functional Protein C Deficiency
Teepe et al.
Arch Dermatol 1986;122:1408-1412.
ABSTRACT  

Dermatologic Problems in the Intensive Care Unit: Part IV
Berman and Silvestri
J Intensive Care Med 1986;1:224-239.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.